NDC 59627-002-07 - AVONEX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59627-002
- Requested NDC
- 59627-002-07
- Package NDCs from labels
- 59627-002-07, 59627-002-06
- Manufacturer
- Biogen Inc. | Packaging Coordinators, LLC
- Effective date
- 2025-11-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AVONEX - Biogen Inc. | Packaging Coordinators, LLC | Biogen Inc. | Packaging Coordinators, LLC | 2025-11-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59627-002-06 | Avonex | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 23 | |
| 59627-002-07 | Avonex | 1 in 1 TRAY | INJECTION, SOLUTION | 1 | 23 | |
| 59627-002-07 | Avonex | 0.5 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.5 | 23 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59627-002 | AVONEX (INTERFERON BETA-1A) KIT AVONEX PEN (INTERFERON BETA-1A) INJECTION, SOLUTION AVONEX (INTERFERON BETA-1A) INJECTION, SOLUTION [BIOGEN INC.] | 22 | Current NDC, Legacy NDC, 3 package rows | 20241115_d70a39cc-de15-4c12-a1ec-8063b69ea0e1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59627-002-05 | EA - Each | 59627-002 | 31696ccb-f2fd-4e79-9d20-4172258cd419 | 1 | 2012-07-24 |
| 59627-002-06 | ML - Milliliter | 59627-002 | a90c5f27-cfdb-465e-8b90-9c2a34c90f3e | 1 | 2021-09-07 |
| 59627-002-07 | ML - Milliliter | 59627-002 | 5e7add05-1932-4c66-9876-ff82ad4af6a8 | 2 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| interferon beta-1a | ACTIVE INGREDIENT | XRO4566Q4R | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| ISOPROPYL ALCOHOL | ACTIVE INGREDIENT | ND2M416302 | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| interferon beta-1a | ACTIVE MOIETY | XRO4566Q4R | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| ISOPROPYL ALCOHOL | ACTIVE MOIETY | ND2M416302 | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| acetic acid | INACTIVE INGREDIENT | Q40Q9N063P | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| Arginine hydrochloride | INACTIVE INGREDIENT | F7LTH1E20Y | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| Sodium acetate | INACTIVE INGREDIENT | 4550K0SC9B | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | AVONEX (INTERFERON BETA-1A) KIT [BIOGEN IDEC INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R ND2M416302 |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | 059QF0KO0R 7T1F30V5YH |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 059QF0KO0R ND2M416302 |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Spa Line | ORYZA SATIVA (RICE) STARCH, PERLITE, PALMITIC ACID | ANUBIS COSMETICS SL | eb01a962-ab38-18ec-e053-2995a90acdeb | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | FERULIC ACID, VITAMIN C, DMAE | ANUBIS COSMETICS SL | eaf0770c-795d-0232-e053-2a95a90ae0b5 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | 059QF0KO0R ND2M416302 |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Total Hydrating | BETAINE, GLYCERIN, POLYSORBATE 20 | ANUBIS COSMETICS SL | eaefe3b9-9064-18b1-e053-2a95a90a5765 | 2023-09-01 | Warnings | 059QF0KO0R 7T1F30V5YH |
| Anubis Barcelona New Even | LACTIC ACID, CITRIC ACID, GLYCOLIC ACID | ANUBIS COSMETICS SL | eaeeb6e0-5322-20c4-e053-2995a90a9fd9 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Vital Line | HYDROLYZED COLLAGEN | ANUBIS COSMETICS SL | f564bbf0-3b5c-4a81-e053-2a95a90a7ea6 | 2023-08-29 | Warnings | 059QF0KO0R |
| Pancreapar | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Energique, Inc. | 99a4560e-f124-4569-a2f1-78ce5995f8e0 | 2023-08-24 | Warnings | Q40Q9N063P |
| Pancreapar | SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM | Energique, Inc. | ba9c13d0-92de-4159-8a35-215e3de50c07 | 2023-08-24 | Warnings | Q40Q9N063P |
| Acetic Acid | ACETIC ACID | B. Braun Medical Inc. | dd45cee3-9938-4dad-a5e1-1dd4baea85a9 | 2023-08-23 | Warnings, Adverse reactions | Q40Q9N063P |
| Aceticum acidum | ACETIC ACID | Boiron | 69214a87-0b8c-702d-e053-2a91aa0a3416 | 2023-07-03 | Q40Q9N063P | |
| Prevantics Maxi Swabstick | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | Professional Disposables International, Inc. | 93ca3c07-40b4-3a91-e053-2995a90a0afd | 2023-06-30 | Warnings | ND2M416302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.